App database

LQCalc

RADLab, K.K.

Store data observed · From public App Store data · How we score apps

  • Medical
  • App Store
  • United States
  • —0 ratings
  • Paid $0.99
  • Updated
  • Observed

Ratings

Observed
0

Chart position

Observed
—Not on the top charts

90-day growth

—not enough history yet

Opportunity score

AI-derived
14/100Weak · low confidence
Own LQCalc? Share your real numbers

Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.

Sign in to share them.

Made LQCalc? Add a “Tracked in Medical” badge to your site
Tracked in Medical badge

About LQCalcObserved

LQCalc is a Medical app by RADLab, K.K. on the United States App Store. Released Mar 1, 2021; last updated Sep 29, 2022 (version 1.3). LQCalc costs $0.99 to download.

MRRBeam rates the success of LQCalc 0/100 (early stage).

LQ model (LinearQuadraticModel)に基づき、放射線治療線量の換算計算を行います。HyperFractionation、再照射線量にも対応しています。 1回線量(Gy)、分割回数(Fr)、α/β値から BED(Biological Effective Dose; 生物学的等価線量) = nd(1 + d/[α/β]) EqD2(Gy等価線量換算値) = 1 回線量 2 Gy換算のnormalized total dose を計算します。 2種類のα/β値で同時計算が可能です。 本アプリの計算結果は、治療の妥当性や正確性等について保証するものではなく、…
From the App Store listing
Success score
0/100 Early stage
In Medical
Outside the top 100
Chart position
Not on the top charts
Developer
RADLab, K.K.
Loading the full report…

LQCalc: common questions

What is LQCalc?
LQCalc is a Medical app developed by RADLab, K.K., available on the App Store. It was first released on Mar 1, 2021.
How much does LQCalc cost?
LQCalc costs $0.99 to download.
Is LQCalc successful?
MRRBeam rates the success of LQCalc 0/100 (early stage). The success score combines rating volume, chart position and average rating.
When was LQCalc last updated?
LQCalc was last updated on Sep 29, 2022 (version 1.3).
What are alternatives to LQCalc?
Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
Is there room to build a competitor to LQCalc?
MRRBeam's opportunity score for LQCalc is 14/100. Limited opening: an older app, little observable demand and low price points.